Back to today’s briefing

Story perspectives

Brainstorm Cell Therapeutics Withdraws SEC Filing to Reclaim Fees

7/23/2025

28 6

Summary

Story summary

On July 22, 2025, Brainstorm Cell Therapeutics Inc. took a significant step by asking the U.S. Securities and Exchange Commission to withdraw its previously filed Registration Statement on Form S-3 from June 25, 2025. With no securities issued and the statement inactive, the company aims to reclaim associated fees for future endeavors.

1 of 1

Story summary

On July 22, 2025, Brainstorm Cell Therapeutics Inc. took a significant step by asking the U.S. Securities and Exchange Commission to withdraw its previously filed Registration Statement on Form S-3 from June 25, 2025. With no securities issued and the statement inactive, the company aims to reclaim associated fees for future endeavors.